Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 17 July, 2019

JP Morgan Sec LLC

ISE Only - AbbVie Inc 38.5b AMENDMENT

RNS Number : 8977F
J.P. Morgan Securities LLC
17 July 2019
 

Ap27

 

AMENDMENT

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.          KEY INFORMATION

 

Name of exempt principal trader

J.P. Morgan Securities LLC

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 1)

Common Stock

Date of dealing

08 July 2019

 

2.          INTERESTS AND SHORT POSITIONS

 

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

7,971,003 (0.54%)

2,053,133 (0.14%)

(2) Derivatives (other than options)

2,821,731 (0.19%)

1,721,723 (0.12%)

(3) Options and agreements to purchase/sell

1,372,700 (0.09%)

1,120,100 (0.08%)

Total

12,165,434 (0.82%)

4,894,956 (0.34%)

             

 

 

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

-

-

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

-

-

             

 

 

 

Ap28

 

 

3.       DEALINGS (Note 3)

 

(a)      Purchases and sales

 

 

Purchases/ sales

 

Number of relevant securities

Price per unit  (USD)

Purchase (New Borrow)

 

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

1,204,300

 

 

2

2

19

6

3

13

23

315

4,600

5

47

2

7

2

1,604

35

14,041

3

510

4,538

1,186

300

32

2

8

4

2

173

2

7

11

813

8

6

7

15

2

32

102

19

2

4

202

867

1,200

4

4

42,195

11

64

49

4

7

2

2

3

3

3

3

2

2

5

5

446

3

3

500

930

270

107

43

180

 

6,100

14,041

3,520

3

33

4,900

1,400

4,700

173

500

602

473

1,000

1,000

600

861

1,335

3,200

9,814

200

400

100

900

200

300

1,200

33

3,591

7,600

28,304

1

446

930

29

200

729

2,000

458

400

1,200

271

20

100

100

90

180

N/A

 

 

70.9000

 70.9200

 70.9500

 70.9600

 70.9700

 70.9800

 70.9900

 71.0000

 71.0070

 71.0100

 71.0147

 71.0200

 71.0300

 71.0400

 71.0416

 71.0417

 71.0479

 71.0500

 71.0600

 71.0628

 71.0634

 71.0667

 71.0775

 71.0800

 71.0825

 71.0900

 71.1000

 71.1058

 71.1200

 71.1214

 71.1218

 71.1262

 71.1300

 71.1400

 71.1500

 71.1533

 71.1600

 71.1625

 71.1700

 71.1763

 71.1800

 71.1900

 71.2000

 71.2006

 71.2047

 71.2050

 71.2100

 71.2200

 71.2300

 71.2384

 71.2396

 71.2400

 71.2500

 71.2700

 71.2800

 71.3600

 71.3800

 71.3900

 71.4000

 71.4200

 71.4800

 71.4900

 71.5000

 71.5004

 71.5200

 71.5400

 71.6000

 71.7268

 71.7356

 72.1800

 72.1900

 72.9900

 

 71.0247

 71.0479

 71.0500

 71.0549

 71.0582

 71.0626

 71.0627

 71.0953

 71.1058

 71.1144

 71.1238

 71.1300

 71.1400

 71.1420

 71.1500

 71.1526

 71.1600

 71.1672

 71.1683

 71.1700

 71.1712

 71.1783

 71.1844

 71.1900

 71.1967

 71.2047

 71.2094

 71.2158

 71.2175

 71.2200

 71.2800

 71.5004

 71.7268

 72.3700

 72.3800

 72.4100

 72.4221

 72.4431

 72.4588

 72.4642

 72.4700

 72.4900

 72.5150

 72.5300

 72.5500

 72.9900

 

 

 

 

 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit (USD)

(Note 4)

Equity Swap

Long

 

 

Short

173

446

 

14,041

1,200

930

71.1058

71.5004

 

71.0479

71.2047

71.7268

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

 

 

 

 

 

 

Ap29

 

4.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)                    Yes

 

 

Date of disclosure

17 July 2019

Contact name

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

Ap31

 

 

SUPPLEMENTAL FORM 38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Purchased

 1,500

105.00

American

19-Jun-20

Call Option

Purchased

 10,000

110.00

American

15-Jan-21

Call Option

Purchased

 8,500

105.00

American

15-Jan-21

Call Option

Purchased

 398,500

75.00

American

16-Aug-19

Call Option

Purchased

 4,200

80.00

American

19-Jun-20

Call Option

Purchased

 2,500

87.50

American

19-Jun-20

Call Option

Purchased

 2,100

90.00

American

19-Jun-20

Call Option

Purchased

 1,800

95.00

American

19-Jun-20

Call Option

Purchased

 900

100.00

American

19-Jun-20

Call Option

Purchased

 10,400

80.00

American

19-Jun-20

Call Option

Purchased

 7,200

95.00

American

19-Jun-20

Call Option

Purchased

 4,200

100.00

American

19-Jun-20

Call Option

Purchased

 3,600

105.00

American

19-Jun-20

Call Option

Purchased

 3,300

110.00

American

19-Jun-20

Call Option

Purchased

 6,100

85.00

American

19-Jun-20

Call Option

Purchased

 2,600

92.50

American

19-Jun-20

Call Option

Purchased

 2,200

95.00

American

19-Jun-20

Call Option

Purchased

 1,100

100.00

American

19-Jun-20

Call Option

Purchased

 1,900

105.00

American

19-Jun-20

Call Option

Purchased

 9,400

85.00

American

19-Jun-20

Call Option

Purchased

 5,800

92.50

American

19-Jun-20

Call Option

Purchased

 3,300

97.50

American

19-Jun-20

Call Option

Purchased

 3,000

105.00

American

19-Jun-20

Call Option

Purchased

 2,800

110.00

American

19-Jun-20

Call Option

Purchased

 2,500

115.00

American

19-Jun-20

Call Option

Purchased

 6,500

80.00

American

19-Jun-20

Call Option

Purchased

 2,700

85.00

American

19-Jun-20

Call Option

Purchased

 2,400

90.00

American

19-Jun-20

Call Option

Purchased

 2,300

97.50

American

19-Jun-20

Call Option

Purchased

 1,000

100.00

American

19-Jun-20

Call Option

Purchased

 37,500

85.00

American

20-Sep-19

Call Option

Written

 20,000

105.00

American

17-Jan-20

Call Option

Written

 6,100

85.00

American

19-Jun-20

Call Option

Written

 2,600

92.50

American

19-Jun-20

Call Option

Written

 2,200

95.00

American

19-Jun-20

Call Option

Written

 1,100

100.00

American

19-Jun-20

Call Option

Written

 1,900

105.00

American

19-Jun-20

Call Option

Written

 200,000

70.00

American

16-Aug-19

Call Option

Written

 4,200

80.00

American

19-Jun-20

Call Option

Written

 2,500

87.50

American

19-Jun-20

Call Option

Written

 2,100

90.00

American

19-Jun-20

Call Option

Written

 1,800

95.00

American

19-Jun-20

Call Option

Written

 900

100.00

American

19-Jun-20

Call Option

Written

 10,400

80.00

American

19-Jun-20

Call Option

Written

 7,200

95.00

American

19-Jun-20

Call Option

Written

 4,200

100.00

American

19-Jun-20

Call Option

Written

 3,600

105.00

American

19-Jun-20

Call Option

Written

 3,300

110.00

American

19-Jun-20

Call Option

Written

 9,400

85.00

American

19-Jun-20

Call Option

Written

 5,800

92.50

American

19-Jun-20

Call Option

Written

 3,300

97.50

American

19-Jun-20

Call Option

Written

 3,000

105.00

American

19-Jun-20

Call Option

Written

 2,800

110.00

American

19-Jun-20

Call Option

Written

 2,500

115.00

American

19-Jun-20

Call Option

Written

 40,000

70.00

American

16-Aug-19

Call Option

Written

 6,500

80.00

American

19-Jun-20

Call Option

Written

 2,700

85.00

American

19-Jun-20

Call Option

Written

 2,400

90.00

American

19-Jun-20

Call Option

Written

 2,300

97.50

American

19-Jun-20

Call Option

Written

 1,000

100.00

American

19-Jun-20

Put Option

Purchased

 45,000

80.00

American

17-Jan-20

Put Option

Purchased

 5,000

60.00

American

19-Jun-20

Put Option

Purchased

 4,200

65.00

American

19-Jun-20

Put Option

Purchased

 5,400

70.00

American

19-Jun-20

Put Option

Purchased

 1,600

75.00

American

19-Jun-20

Put Option

Purchased

 11,000

60.00

American

19-Jun-20

Put Option

Purchased

 9,400

65.00

American

19-Jun-20

Put Option

Purchased

 15,800

70.00

American

19-Jun-20

Put Option

Purchased

 4,300

77.50

American

19-Jun-20

Put Option

Purchased

 5,900

60.00

American

19-Jun-20

Put Option

Purchased

 5,100

65.00

American

19-Jun-20

Put Option

Purchased

 4,400

70.00

American

19-Jun-20

Put Option

Purchased

 3,800

75.00

American

19-Jun-20

Put Option

Purchased

 1,800

77.50

American

19-Jun-20

Put Option

Purchased

 22,400

55.00

American

19-Jun-20

Put Option

Purchased

 7,800

65.00

American

19-Jun-20

Put Option

Purchased

 6,700

70.00

American

19-Jun-20

Put Option

Purchased

 6,000

75.00

American

19-Jun-20

Put Option

Purchased

 2,800

77.50

American

19-Jun-20

Put Option

Purchased

 6,700

55.00

American

19-Jun-20

Put Option

Purchased

 5,600

60.00

American

19-Jun-20

Put Option

Purchased

 4,800

65.00

American

19-Jun-20

Put Option

Purchased

 4,400

67.50

American

19-Jun-20

Put Option

Purchased

 1,900

72.50

American

19-Jun-20

Put Option

Purchased

 17,500

80.00

American

20-Sep-19

Put Option

Purchased

 20,000

75.00

American

20-Sep-19

Put Option

Written

 15,600

72.50

American

19-Jul-19

Put Option

Written

 5,900

60.00

American

19-Jun-20

Put Option

Written

 5,100

65.00

American

19-Jun-20

Put Option

Written

 4,400

70.00

American

19-Jun-20

Put Option

Written

 3,800

75.00

American

19-Jun-20

Put Option

Written

 1,800

77.50

American

19-Jun-20

Put Option

Written

 5,000

60.00

American

19-Jun-20

Put Option

Written

 4,200

65.00

American

19-Jun-20

Put Option

Written

 5,400

70.00

American

19-Jun-20

Put Option

Written

 1,600

75.00

American

19-Jun-20

Put Option

Written

 11,000

60.00

American

19-Jun-20

Put Option

Written

 9,400

65.00

American

19-Jun-20

Put Option

Written

 15,800

70.00

American

19-Jun-20

Put Option

Written

 4,300

77.50

American

19-Jun-20

Put Option

Written

 22,400

55.00

American

19-Jun-20

Put Option

Written

 7,800

65.00

American

19-Jun-20

Put Option

Written

 6,700

70.00

American

19-Jun-20

Put Option

Written

 6,000

75.00

American

19-Jun-20

Put Option

Written

 2,800

77.50

American

19-Jun-20

Put Option

Written

 60,000

70.00

American

16-Aug-19

Put Option

Written

 1,000

70.00

American

17-Jan-20

Put Option

Written

 6,700

55.00

American

19-Jun-20

Put Option

Written

 5,600

60.00

American

19-Jun-20

Put Option

Written

 4,800

65.00

American

19-Jun-20

Put Option

Written

 4,400

67.50

American

19-Jun-20

Put Option

Written

 1,900

72.50

American

19-Jun-20

Put Option

Purchased

117,500

55.00

American

15-Nov-19

Call Option

Written

117,500

70.00

American

15-Nov-19

Put Option

Purchased

10,000

110.00

American

17-Jan-20

Put Option

Purchased

140,000

82.50

American

15-Jan-21

Put Option

Written

7,500

60.00

American

26-Jul-19

Put Option

Written

50,000

60.00

American

17-Jan-20

Call Option

Purchased

50,000

80.00

American

17-Jan-20

Call Option

Purchased

90,000

77.50

American

16-Aug-19

Call Option

Written

100,000

72.50

American

16-Aug-19

Put Option

Purchasing

50,000

67.50

American

16-Aug-19

Put Option

Written

200,000

74.00

American

19-Jul-19

Put Option

Written

200,000

72.50

American

16-Aug-19

 

 

Notes

 

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.       For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELLFFRDDIDLIA

a d v e r t i s e m e n t